ZIOPHARM ONCOLOGY INC's ticker is ZIOP and the CUSIP is 98973P101. A total of 137 filers reported holding ZIOPHARM ONCOLOGY INC in Q3 2018. The put-call ratio across all filers is 1.86 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $28,135 | -48.3% | 25,812 | -13.7% | 0.00% | -100.0% |
| Q3 2021 | $54,440 | -65.1% | 29,912 | -49.4% | 0.00% | -50.0% |
| Q2 2021 | $156,211 | -27.5% | 59,171 | -1.1% | 0.00% | -33.3% |
| Q1 2021 | $215,384 | +42.3% | 59,829 | -0.4% | 0.00% | +50.0% |
| Q4 2020 | $151,351 | -2.3% | 60,060 | -2.3% | 0.00% | -33.3% |
| Q3 2020 | $154,942 | -30.0% | 61,485 | -8.9% | 0.00% | -25.0% |
| Q2 2020 | $221,452 | +116.0% | 67,516 | +61.4% | 0.00% | +100.0% |
| Q1 2020 | $102,510 | -48.5% | 41,841 | -0.9% | 0.00% | -33.3% |
| Q4 2019 | $199,189 | -14.2% | 42,201 | -22.2% | 0.00% | -25.0% |
| Q3 2019 | $232,207 | -14.3% | 54,254 | +16.7% | 0.00% | -20.0% |
| Q2 2019 | $271,077 | +57.1% | 46,497 | +3.8% | 0.01% | +66.7% |
| Q1 2019 | $172,522 | +107.6% | 44,811 | +0.8% | 0.00% | +50.0% |
| Q4 2018 | $83,103 | -41.6% | 44,440 | 0.0% | 0.00% | -33.3% |
| Q3 2018 | $142,208 | -99.9% | 44,440 | 0.0% | 0.00% | +50.0% |
| Q2 2018 | $134,209,000 | -16.0% | 44,440 | +9.0% | 0.00% | 0.0% |
| Q1 2018 | $159,779,000 | +114848.9% | 40,760 | +21.4% | 0.00% | 0.0% |
| Q4 2017 | $139,000 | -74.8% | 33,572 | -62.2% | 0.00% | -50.0% |
| Q2 2017 | $552,000 | -1.8% | 88,717 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $562,000 | +23.8% | 88,717 | +4.6% | 0.00% | +33.3% |
| Q4 2016 | $454,000 | -10.1% | 84,831 | -5.5% | 0.00% | -25.0% |
| Q3 2016 | $505,000 | +2.6% | 89,763 | +0.3% | 0.00% | 0.0% |
| Q2 2016 | $492,000 | -17.6% | 89,527 | +11.2% | 0.00% | -20.0% |
| Q1 2016 | $597,000 | -10.8% | 80,524 | 0.0% | 0.01% | 0.0% |
| Q4 2015 | $669,000 | -7.9% | 80,524 | 0.0% | 0.01% | 0.0% |
| Q3 2015 | $726,000 | -24.8% | 80,524 | 0.0% | 0.01% | -28.6% |
| Q2 2015 | $966,000 | +26.8% | 80,524 | +13.8% | 0.01% | +16.7% |
| Q1 2015 | $762,000 | +149.0% | 70,750 | +17.3% | 0.01% | +200.0% |
| Q4 2014 | $306,000 | +92.5% | 60,334 | 0.0% | 0.00% | +100.0% |
| Q3 2014 | $159,000 | -34.6% | 60,334 | 0.0% | 0.00% | -50.0% |
| Q2 2014 | $243,000 | -12.0% | 60,334 | 0.0% | 0.00% | 0.0% |
| Q1 2014 | $276,000 | +5.3% | 60,334 | 0.0% | 0.00% | 0.0% |
| Q4 2013 | $262,000 | +10.1% | 60,334 | 0.0% | 0.00% | 0.0% |
| Q3 2013 | $238,000 | – | 60,334 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MSD Partners, L.P. | 10,986,258 | $20,544,000 | 1.80% |
| Third Security, LLC | 4,364,080 | $8,161,000 | 1.11% |
| MILLER VALUE PARTNERS, LLC | 9,264,700 | $16,617,000 | 0.75% |
| Sargent Investment Group, LLC | 188,950 | $353,000 | 0.22% |
| Chessman Wealth Strategies RIA | 72,050 | $135,000 | 0.14% |
| Ibex Investors LLC | 403,650 | $755,000 | 0.12% |
| Old West Investment Management, LLC | 223,319 | $417,000 | 0.11% |
| PIPER SANDLER & CO. | 34,222 | $64,000 | 0.07% |
| Virtus ETF Advisers LLC | 102,888 | $192,000 | 0.03% |
| G&S Capital LLC | 18,000 | $34,000 | 0.03% |